Rafferty Asset Management
TCRT icon

Rafferty Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Rafferty Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,470
Closed -$379K – 1156
2022
Q3 		$379K Buy
+1,470
New +$427K ﹤0.01% 922
2022
Q1 		– Sell
-5,440
Closed -$889K – 1322
2021
Q4 		$889K Buy
5,440
+2,764
+103% +$607K ﹤0.01% 928
2021
Q3 		$731K Buy
2,676
+167
+7% +$51.1K 0.01% 956
2021
Q2 		$993K Sell
2,509
-1,083
-30% -$506K 0.01% 902
2021
Q1 		$1.94M Buy
3,592
+3,150
+713% +$1.96M 0.01% 637
2020
Q4 		$167K Sell
442
-924
-68% -$367K ﹤0.01% 997
2020
Q3 		$516K Buy
1,366
+940
+221% +$415K 0.01% 689
2020
Q2 		$210K Buy
426
+318
+294% +$142K ﹤0.01% 920
2020
Q1 		$40K Sell
108
-805
-88% -$417K ﹤0.01% 580
2019
Q4 		$646K Sell
913
-1,664
-65% -$1.15M 0.01% 650
2019
Q3 		$1.65M Buy
2,577
+1,225
+91% +$972K 0.03% 434
2019
Q2 		$1.18M Sell
1,352
-43
-3% -$29.6K 0.02% 527
2019
Q1 		$806K Buy
+1,395
New +$583K 0.01% 588

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Addison Capital Conshohocken, Pennsylvania $562M AUM 18.57% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Rafferty Asset Management's TCRT Position: Q4 2022 in Review

Rafferty Asset Management sold out of Alaunos Therapeutics (TCRT) in Q4 2022, closing a stake of 1,470 shares — an estimated $379K sold.

Rafferty Asset Management first reported a position in TCRT in Q1 2019 and held it in 13 quarters. The position peaked at $1.94M in Q1 2021. 122 funds tracked by Wall St. Rank hold TCRT as of Q4 2022.

  • Rafferty Asset Management reported no remaining Alaunos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 1,470 Alaunos Therapeutics shares in Q4 2022, an estimated $379K.
  • Rafferty Asset Management first reported a position in Alaunos Therapeutics in Q1 2019 and held it in 13 quarters.
  • Rafferty Asset Management's Alaunos Therapeutics position peaked at $1.94M in Q1 2021.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2022.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.